rs370587517
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005051.3(QARS1):c.1999C>T(p.Arg667Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,614,024 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005051.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
QARS1 | NM_005051.3 | c.1999C>T | p.Arg667Trp | missense_variant | 21/24 | ENST00000306125.12 | NP_005042.1 | |
QARS1 | NM_001272073.2 | c.1966C>T | p.Arg656Trp | missense_variant | 21/24 | NP_001259002.1 | ||
QARS1 | XM_017006965.3 | c.1999C>T | p.Arg667Trp | missense_variant | 21/23 | XP_016862454.2 | ||
QARS1 | NR_073590.2 | n.1974C>T | non_coding_transcript_exon_variant | 21/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
QARS1 | ENST00000306125.12 | c.1999C>T | p.Arg667Trp | missense_variant | 21/24 | 1 | NM_005051.3 | ENSP00000307567 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152146Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000167 AC: 42AN: 251346Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135856
GnomAD4 exome AF: 0.000101 AC: 148AN: 1461878Hom.: 1 Cov.: 31 AF XY: 0.000105 AC XY: 76AN XY: 727246
GnomAD4 genome AF: 0.000112 AC: 17AN: 152146Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74334
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2022 | QARS1: PM2:Supporting, BP4 - |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2022 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 667 of the QARS protein (p.Arg667Trp). This variant is present in population databases (rs370587517, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with QARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 477837). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at